
Sign up to save your podcasts
Or
Dr. Stephen Waxman is a professor of neurology, neuroscience and pharmacology at Yale. His research on pain helped pave the way for a newly approved, non-addictive pain drug called suzetrigine.
On today’s show, he explains why he thinks suzetrigine is a promising step, but why much more work is needed to develop better pain drugs. He also gets into his work on ion channels—critical to unlocking the pain puzzle— and a rare condition known as Man on Fire syndrome.
See omnystudio.com/listener for privacy information.
4.5
242242 ratings
Dr. Stephen Waxman is a professor of neurology, neuroscience and pharmacology at Yale. His research on pain helped pave the way for a newly approved, non-addictive pain drug called suzetrigine.
On today’s show, he explains why he thinks suzetrigine is a promising step, but why much more work is needed to develop better pain drugs. He also gets into his work on ion channels—critical to unlocking the pain puzzle— and a rare condition known as Man on Fire syndrome.
See omnystudio.com/listener for privacy information.
44,014 Listeners
32,103 Listeners
30,686 Listeners
26,180 Listeners
59,175 Listeners
4,128 Listeners
9,533 Listeners
9,641 Listeners
570 Listeners
14,420 Listeners
6,332 Listeners
5,142 Listeners
406 Listeners
73 Listeners
1,803 Listeners
4,422 Listeners
2,113 Listeners
80 Listeners
458 Listeners
2,288 Listeners
1,234 Listeners
231 Listeners
4,470 Listeners
491 Listeners
432 Listeners
148 Listeners
332 Listeners
374 Listeners
96 Listeners
78 Listeners
1,649 Listeners
254 Listeners
59 Listeners